Mirati Therapeutics
MRTX
#3422
Rank
NZ$7.52 B
Marketcap
NZ$107.30
Share price
0.00%
Change (1 day)
52.89%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): NZ-$19.72

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$22.34. In 2022 the company made an earnings per share (EPS) of NZ-$24.09 a decrease over its 2021 EPS that were of NZ-$20.42.

EPS history for Mirati Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$19.72-18.17%
2022NZ-$24.0917.99%
2021NZ-$20.4240.5%
2020NZ-$14.5340.96%
2019NZ-$10.3177.92%
2018NZ-$5.7913.62%
2017NZ-$5.10-33.57%
2016NZ-$7.6810.82%
2015NZ-$6.9316.98%
2014NZ-$5.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
TravelCenters of America
TA
NZ$17.40-177.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ-$0.11-99.51% Bahamas